Heart Septal Defects, Ventricular
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
AbbottABBOTT PARK, IL
1 programDevice closure with the AMPLATZER Muscular VSD OccluderN/A1 trial
Active Trials
PFM MedicalCA - Carlsbad
1 programtranscatheter implantation of a VSD occluderN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
PFM Medicaltranscatheter implantation of a VSD occluder
AbbottDevice closure with the AMPLATZER Muscular VSD Occluder
Clinical Trials (2)
Total enrollment: 194 patients across 2 trials
Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System
Start: Oct 2006Est. completion: May 2017103 patients
N/ACompleted
Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder
Start: Jul 2000Est. completion: Nov 200991 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.